Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2020 Jun;84(6S Suppl 5):S446-S450.
doi: 10.1097/SAP.0000000000002271.

Injectable Microannealed Porous Scaffold for Articular Cartilage Regeneration

Christine Schaeffer  1 , Blaise N Pfaff  2 , Nicholas J Cornell  2 , Lisa S Salopek  1 , Sarah Shan  3 , Jan Viyar  2 , Wilson Omesiete  1 , Donald R Griffin  2 , Patrick S Cottler  1 , Brent R DeGeorge Jr  1
Affiliations

Injectable Microannealed Porous Scaffold for Articular Cartilage Regeneration

Christine Schaeffer et al. Ann Plast Surg. 2020 Jun.

Abstract

Background: The purpose of this study is to assess the feasibility of a novel microporous annealed particle (MAP) scaffolding hydrogel to enable both articular cartilage and subchondral bone biointegration and chondrocyte regeneration in a rat knee osteochondral defect model.

Methods: An injectable, microporous scaffold was engineered and modified to match the mechanical properties of articular cartilage. Two experimental groups were utilized-negative saline control and MAP gel treatment group. Saline and MAP gel were injected into osteochondral defects created in the knees of Sprague-Dawley rats. Photo-annealing of the MAP gel was performed. Qualitative histologic and immunohistochemical analysis was performed of the treated defects at 2, 4, and 8 weeks postsurgery.

Results: The injectable MAP gel successfully annealed and was sustained within the osteochondral defect at each timepoint. Treatment with MAP gel resulted in maintained size of the osteochondral defect with evidence of tissue ingrowth and increased glycosaminoglycan production, whereas the control defects presented with evidence of disorganized scar tissue. Additionally, there was no significant inflammatory response to the MAP gel noted on histology.

Conclusions: We have demonstrated the successful delivery of an injectable, flowable MAP gel scaffold into a rat knee osteochondral defect with subsequent annealing and stable integration into the healing wound. The flowable nature of this scaffold allows for minimally invasive application, for example, via an arthroscopic approach for management of wrist arthritis. The MAP gel was noted to fill the osteochondral defect and maintain the defect dimensions and provide a continuous and smooth surface for cartilage regeneration, suggesting its ability to provide a stable scaffold for tissue ingrowth. Future chemical, mechanical, and biological gel modifications may improve objective evidence of cartilage regeneration.

PubMed Disclaimer

References

    1. Murphy LB, Cisternas MG, Pasta DJ, et al. Medical expenditures and earnings losses among US adults with arthritis in 2013. Arthritis Care Res. 2018;70:869–876.
    1. Obert L, Lepage D, Ferrier M, et al. Rib cartilage graft for posttraumatic or degenerative arthritis at wrist level: 10-year results. J Wrist Surg. 2013;2:234–238.
    1. Medved F, Gonser P, Lotter O, et al. Severe posttraumatic radiocarpal cartilage damage: first report of autologous chondrocyte implantation. Arch Orthop Trauma Surg. 2013;133:1469–1475.
    1. Mobasheri A, Kalamegam G, Musumeci G, et al. Chondrocyte and mesenchymal stem cell-based therapies for cartilage repair in osteoarthritis and related orthopaedic conditions. Maturitas. 2014;78:188–198.
    1. Yang SW, Ku KC, Chen SY, et al. Development of chondrocyte-seeded electrosprayed nanoparticles for repair of articular cartilage defects in rabbits. J Biomater Appl. 2018;32:800–812.

LinkOut - more resources